We are live on ! Find out more
ACHV icon

Achieve Life Sciences

34 hedge funds and large institutions have $4M invested in Achieve Life Sciences in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $3.04M → $4M (+$962K)

11% less funds holding

Funds holding: 3834 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.91%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
10
Closed
8
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
+$51K

ACHV Hedge Fund Activity: Q2 2016 in Review

34 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2016, worth a combined $4M — up 32% from $3.04M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ACHV and 4 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $64.7K. The largest seller was Panagora Asset Management, cutting an estimated $175K.

  • 34 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2016, down from 38 in Q1 2016.
  • Funds reported $4M of Achieve Life Sciences stock for Q2 2016, up 32% quarter-over-quarter.
  • 4 funds opened new Achieve Life Sciences positions in Q2 2016 and 8 closed out, a net change of -4 holders.
  • The largest Achieve Life Sciences buyer in Q2 2016 was Renaissance Technologies, an estimated $64.7K added.
  • The largest Achieve Life Sciences seller in Q2 2016 was Panagora Asset Management, an estimated $175K sold.

Based on aggregated 13F filings for Q2 2016.